Option Care Health (OPCH) Proxy filing summary

Executive summary

• Definitive agreement provides for an all-cash acquisition by CD&R and McKesson for approximately $5.8 billion; investor materials state $32.05 per share.

• Closing is expected in H1 2027, subject to customary conditions, including stockholder and regulatory approvals.

• The transaction is intended to support strategic investment, faster advanced-technology deployment, improved clinical outcomes and lower total cost of care.

Voting matters and shareholder proposals

• Stockholder approval is a closing condition; preliminary proxy materials will be filed, followed by a definitive proxy statement for stockholders.

• Stockholders are urged to review the definitive proxy statement and related SEC filings when available.

Board of directors and corporate governance

• The board unanimously approved the transaction.

• After closing, the business is expected to remain a separate company led by its own management team.